Session Name: Managing Pain: Optimizing Efficacy without Compromising Safety

Time: October 9, 2024

We appreciate your time and effort in participating in this CME Sessional Evaluation. This evaluation is a pipeline to bring your voice to the leadership, instructors, and CME team. We value your voice and try our best to improve the quality of future activities.

*
*
Did/Will you use this information for specific patient(s)?
What patient/health care problem recently challenged you, and you wish you knew more about?
Comments and Feedback on the learning experience, content, procedure, and instructors, etc. in this session.
As a result of my participation in this activity, I am better able to... 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly disagree
1234
Recognize and avoid high-risk opioid prescribing for the management of pain
Leverage clinical decision support to promote evidence-based and safe prescribing for the management of pain
Implement practical risk mitigation strategies into one's practice
Review investigational pain medications and identify potential future opportunities to incorporate them into one's practice
The following speaker(s) demonstrated experiential knowledge of the topic 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
William Peppard, PharmD, BCPS, FCCM
Choose the option that best fits your evaluation of this activity: 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
The content provided a fair and balanced coverage of the topic
The content was free of commercial bias